INBX
Inhibrx Biosciences, Inc.
97.00$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -45,584.0% | -3,477.4% | – | -57,358.0% | – | -43,720.0% | – | -2,304.1% | – | – | – | – | – | |
| 255.5% | 18.2% | – | 475.0% | – | 689.0% | – | 50.8% | – | – | – | – | – | |
| 5,487.4% | 139.0% | – | 47,528.0% | – | 2,982.0% | – | 213.1% | – | – | – | – | – | |
| -9,222.7% | 1,735.3% | – | 35,491.0% | – | 4.0% | – | -446.2% | – | – | – | – | – | |
| 681.5% | 210.6% | – | 1,215.0% | – | 16.0% | – | 0.0% | – | – | – | – | – | |
| -681.5% | -210.6% | – | -1,215.0% | – | -16.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 0.0% | – | – | – | – | – | |
| 167,975.6% | 52.6% | – | 32,950.0% | – | 0.0% | – | 0.0% | – | – | – | – | – | |
| 121,710.1% | 17,008.8% | – | -25,623.0% | – | -43,736.0% | – | -2,304.1% | – | – | – | – | – | |
| -46,265.5% | -3,688.1% | – | -58,573.0% | – | -43,736.0% | – | -2,304.1% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.